Smith & Nephew: British orthopaedic dividend

The company, which is slumping to this year's lows after its latest quarterly results, was founded in 1856 in England by Thomas James Smith as a pharmacy. After his death in 1896, the company was taken over by his nephew Horatio Nelson Smith, who renamed the company Smith & Nephew. Today, the company specializes in the development, manufacture and distribution of medical devices and is one of the leaders in the industry.

Smith & Nephew operates in several key areas, including orthopedics, sports medicine, endoscopy and wound care. Its main products include artificial joints (hip and knee implants), sports medicine devices, endoscopic instruments and advanced wound care products.

The company places a strong emphasis on innovation and quality, enabling it to provide medical solutions that significantly improve patients' lives. With more than a century of history, Smith & Nephew is synonymous with reliability and excellence in healthcare, enabling it to maintain its market leadership and…

👉 Activate Bulios Black membership to access all analyses

The first 7 days are free!
Make stock selection easier with thorough analysis of top companies
Track the performance of your portfolio and dividends in the portfolio tracker
Get a detailed overview of the fair prices of thousands of popular companies
Improve your stock analysis with advanced artificial intelligence StockBot 1.0
Activate free
Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Menu StockBot
Tracker
Upgrade